Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Torrent's Fluoxetine vs Sarafem in Healthy Subjects (Fed)
NCT02965274Phase 1Completed
- Sponsor
- Torrent Pharmaceuticals Limited
- Start
- Nov 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of fluoxetine in Premenstrual Dysphoric Disorder (PMDD) (2 arms), sponsored by Torrent Pharmaceuticals Limited. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve. Started Nov 2013; status: completed.
02
Drugs
fluoxetine
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on NCT02965274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02965274.